GeneXpert Infinity-48 is the World's First Fully-Automated Random Access
Molecular Diagnostic Testing System; On Display at AACC Meeting
SUNNYVALE, Calif., July 29 /PRNewswire-FirstCall/ -- Cepheid (Nasdaq: CPHD) today introduced its GeneXpert(R) Infinity-48 high-throughput system at the 2008 American Association for Clinical Chemistry Annual Meeting in Washington, D.C. The newest addition to Cepheid's GeneXpert family of molecular diagnostic testing systems delivers the world's first and only fully-automated random access system designed for management of the entire molecular testing workflow. After a sample is loaded into a GeneXpert cartridge, the Infinity-48 System does the rest -- sample in, answer out. The Infinity-48 manages the sample data, cartridge loading and unloading and reporting of test results.
"Cepheid's GeneXpert Infinity-48 System represents the pinnacle of molecular diagnostics automation today," said Cepheid CEO John Bishop. "With an expanding pipeline of on-demand tests in the Infectious Disease, Oncology, and Genetic Disease markets, the Infinity Series of Systems is positioned to become the platform of choice for high-throughput laboratories."
Cepheid's GeneXpert Infinity-48 System uses robotic cartridge handling, managed by Cepheid's Xpertise(TM) software package and full touch screen driven menu, to run up to 1,300 different molecular tests during any 24-hour period, depending upon test selection. With each of the system's 48 testing modules managed as an independent testing site, the Infinity-48 System can start test runs anytime samples are collected -- 24 hours a day, 365 days a year. Delivering true walk away ease-of-use, the Infinity-48 System is positioned to improve workflow while further accelerating time-to-result, enabling healthcare providers to make more informed patient management and treatment decisions.
The Infinity-48 System can be configured with 16, 24, 32, 40, or 48
modules. To han
Copyright©2008 PR Newswire.
All rights reserved